经桡动脉与经股动脉入路治疗肝细胞癌的系统综述与Meta分析
该系统综述与Meta分析纳入11项研究共2535例肝细胞癌手术,比较经桡动脉入路与经股动脉入路行肝血管造影。结果显示两种入路在透视时间、辐射剂量、对比剂剂量及入路失败率上无显著差异,经股动脉入路不良事件 odds 显著更高,患者因住院时间短和术后不适少而更偏好经桡动脉入路。
要点
- 经桡动脉与经股动脉入路在透视时间、辐射剂量和对比剂剂量上无显著差异。
- 经股动脉入路不良事件(除外入路失败)的 odds 显著更高,总体并发症率相当。
- 患者因住院时间短和术后不适少而更偏好经桡动脉入路。
核心结论
- 该Meta分析支持在肝细胞癌肝血管造影肿瘤手术中使用经桡动脉入路,患者偏好亦倾向经桡动脉入路。
研究设计与样本
- 按PRISMA指南进行的系统综述与Meta分析,纳入11项研究共2535例肝细胞癌手术,使用RevMan 5.4软件进行统计分析。
诊断标准与关键数值
- 连续结局以均数差计算,二分类结局以比值比测量。
- 经桡动脉与经股动脉入路在透视时间、辐射剂量和对比剂剂量上无显著差异。
- 两种入路入路失败率相似。
- 经股动脉入路不良事件(除外入路失败)的 odds 显著更高,总体并发症率相当。
临床应用与阅片要点
- 该Meta分析支持在肝细胞癌肝血管造影肿瘤手术中使用经桡动脉入路。
- 患者因住院时间短和术后不适少而强烈偏好经桡动脉入路。
- 作者鼓励开展更多随机临床试验以进一步评估两种入路部位的可行性和获益。
局限性
- 作者鼓励开展更多随机临床试验以进一步评估两种入路部位的可行性和获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: Hepatic angiography procedures are essential in the treatment of hepatocellular carcinoma (HCC), with traditional transfemoral arterial (TFA) access being the traditional standard. Recently, transradial arterial (TRA) access has gained popularity, offering potential benefits. This study aims to conduct a systematic review and meta-analysis to compare TRA and TFA access in hepatic angiography oncologic procedures for HCC. The study investigates fluoroscopy time, radiation dose, patient preferences, and complications associated with each access method.
MATERIAL AND METHODS: A systematic review was performed using PRISMA guidelines, with 11 studies encompassing 2535 HCC procedures included. Statistical analysis was conducted using RevMan 5.4 software. Continuous outcomes were calculated as mean differences, and binary outcomes were measured as odds ratios. Patient preferences, procedural complications, and access site success rates were assessed.
RESULTS: The meta-analysis revealed that there were no significant differences in fluoroscopy time, radiation dose, or contrast dose between TRA and TFA. Access failure rates were similar for both methods. However, the odds of adverse events, excluding access failure, were significantly higher for TFA, while the overall rate of complications was comparable. Patients strongly preferred TRA over TFA due to reduced hospital stay and post-procedure discomfort.
CONCLUSION: This meta-analysis supports the use of TRA for hepatic angiography oncologic procedures for HCC with patient preferences in favor of TRA. Additional randomized clinical trials are encouraged to further evaluate the feasibility and benefits of both access sites.
引用
- Worley L, Szekeres D, Akkipeddi SM, et al. Transradial versus transfemoral access for treatment of HCC: a systematic review and meta analysis. Clin Radiol. 2024. PMID: 39174420. doi:10.1016/j.crad.2024.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。